MORE►
precision medicine
Caris Life Sciences has begun the commercial launch of a blood test designed to detect early signals for multiple types of cancer. [Photo: Caris Life Sciences]
Caris Life Sciences Begins Commercial Launch of Multi-Cancer Early Detection Blood Test
by Lauren Lawley Head | Jul 6, 2026
“We are giving physicians and patients a powerful new tool to help identify cancer earlier and support more informed clinical decisions,” CEO David Dean Halbert says of Caris Detect.
by Sandra Engelland |
Dec 17, 2025
Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial, and net sales payments, as well as potential tiered royalties on net sales of collaboration therapies, the company said.
MORE►
by Lance Murray |
May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
MORE►
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Irving’s Caris Life Sciences Raises $830M to Grow Its Precision Medicine Platform for Cancer Care
by Alex Edwards | May 12, 2021
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Lance Murray |
Mar 2, 2018
The new center, on the campus of UT Arlington, will be available to academic and corporate researchers. Official said it could help elevate the region as a leader in precision medicine.
MORE►
by Hubert Zajicek |
Jan 9, 2017
Artificial intelligence, emancipating role of health care consumers, and genetic testing are some of the trends to expect in 2017 Hubert Zajicek says.
MORE►
